| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 7.95 | 0.05 (+0.63%) | 4.41 - 8.50 | 778.2 thousand (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 7.96 |
|---|---|
| Previous Close | 7.90 |
| Day's Range | 7.81 - 8.05 |
| Market Cap | 380.6M |
| Avg Volume (10 Day) | 1.1M |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -1.57 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
No news headlines available for TSRX
| TSRX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -60.36% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 19.82 |
| Company | Last | Change |
|---|---|---|
| TearLab Corp | 10.07 | -2.04% |
| Nordion Inc | 7.80 | -2.74% |
| China Cord Blood Corp | 2.80 | 0.00% |
| Neogenomics Inc | 3.60 | -4.76% |
| Novadaq Technologies Inc | 13.53 | -0.29% |
Data is delayed by at least 15 min.